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Effects of quinoline-arylamidine hybrids on  
LPS-induced inflammation in RAW 264.7 cells 
Abstract
Background and purpose: Inflammation is a common pathogenesis 
in infection, injury, cancer, and many chronic diseases. Macrophages are 
among the main cells involved in generation of inflammation. The aim of 
the present study was to investigate the effects of molecular hybrids with 
7-chloroquinoline and arylamidine moieties joined through flexible a 
2-aminoethanol linker, on the in vitro inflammatory responses to lipopoly-
saccharides (LPS) induced inflammation in the RAW 264.7 cells. 
Materials and methods: To determine effects of seven quinoline-aryl-
amidine hybrids on the growth of the murine macrophage-like (RAW 
264.7) cells MTT assay was used. Inflammatory reactions in the RAW264.7 
cells were induced using E. coli lipopolysaccharides (LPS). Levels of nitric 
oxide (NO) and malondialdehyde (MDA) were determined by spectropho-
tometry methods. Intracellular production of reactive oxygen species (ROS) 
was measured by flow cytometry. Antioxidant capacity of tested compounds 
was tested by 2,2’-azino-bis(3-ethybenzthiazoline-6-sulfonic acid (ABTS) 
radical cation method.
Results: Tested hybrid compounds differentially influenced proliferation 
of non-stimulated and LPS-stimulated RAW 264.7 cells. The hybrid com-
pounds have not presented ABTS radical-scavenger activity. In the LPS-
stimulated RAW 264.7 cells 10 μM compounds slightly decreased produc-
tion of NO and ROS and significantly modulated LPS-induced lipid 
peroxidation. 
Conclusions: Molecular hybrids with 7-chloroquinoline and arylami-
dine moieties joined through flexible 2-aminoethanol linker markedly de-
creased accumulation of lipid peroxidation products in the LPS-stimulated 
RAW 264.7 cells. Further studies are necessary to determine their mecha-
nism of anti-inflammatory action in more details. 
INTRODUCTION
Inflammation is a common pathophysiological process in infection, injury, cancer, and many chronic diseases including autoimmune 
diseases, diabetes, Alzheimer’s disease, cardiovascular and inflamma-
tory bowel diseases (1). Although in the last two decades anti-inflam-
matory therapy in chronic diseases triggered by inflammation, deregu-
lation or autoimmunity has significantly improved, there are considerable 
limitations while treatment choices of inflammatory process often ex-
press side effects or/and lack of effectiveness. For that reason, there is a 
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Nitrogen-containing heterocyclic molecules are oblig-
atory structural units in medicinal chemistry with diverse 
applications. Among them, quinoline and its derivatives 
have attracted considerable attention due to their various 
pharmacological activities including antitumor, antioxi-
dant, antiproliferative (3), and anti-inflammatory activity 
(4, 5, 6). Having in mind that new drug development 
strategies are focusing on molecules that act simultane-
ously on multiple targets, either by a combination of at 
least two drugs or by combining two (or more) active 
pharmacophores in the single-hybrid molecule that has 
dual activity (7, 8), we recently reported on the synthesis 
and antitumor activity of four series of new molecular 
hybrids containing 7-chloroquinoline and arylamidine 
moieties joined through the rigid -O- or flexible -NH-
CH2-CH2-O- linker (9).
We found that the new hybrid molecules with 7-chlo-
roquinoline displayed selectivity on carcinoma and leu-
kemia cells, showing higher efficacy against leukemia cells 
(10).
Since the causal relationship between inflammation, 
innate immunity and cancer is more widely accepted and 
cancer-related inflammation has been proposed to pro-
mote tumor progression and serve as the seventh hallmark 
of tumor, we decided to expand our investigation to test 
anti-inflammatory potential of selected hybrid com-
pounds.
Macrophages are the cornerstone of the innate im-
mune system, which activation plays a significant role in 
homeostasis of organisms (11). In vitro macrophage activa-
tion techniques provide us with a window to understand 
the mechanisms of inflammation and response of macro-
phages to the modulating interventions (12). Nitric oxide 
(NO) is an important pro-inflammatory mediator pro-
duced by inducible nitric oxide synthase (iNOS) during 
conversion of l-arginine to l-citrulline. The reaction of 
NO with superoxide anion will form a strong cytotoxic 
oxidant, peroxynitrite, which increases the production of 
PGs and causes lipid peroxidation and cellular damage 
(13). Pro-inflammatory cytokines are produced in large 
quantities by activated macrophages/monocytes that 
stimulate cellular responses via increasing prostaglandins 
(PGs) and reactive oxygen species (ROS). Additionally, 
lipid peroxidation (malondialdehyde, MDA) is produced 
by free radicals attacking the cell membranes. Thus, in-
flammatory effect results in the accumulation of MDA.  
The aim of the present study was to investigate in vitro 
anti-inflammatory potential of molecular hybrids with 
7-chloroquinoline and arylamidine moieties joined 
through flexible 2-aminoethanol linker. The anti-inflam-
matory activities of selected hybrids were evaluated by 
means of inhibiting reactive oxygen species (ROS) and 
nitric oxide (NO) production as well as MDA accumula-
tion in the lipopolysaccharides (LPS) induced RAW 
264.7 cells.  
MATERIAL AND METHODS
Compounds
The synthesis, physical properties, and antitumor ac-
tivity of new molecular hybrids with 7-chloroquinoline 
and arylamidine moieties joined through flexible 2-ami-
noethanol linker have been described previously (9). 
Structural details of all studied molecules are shown in 
Figure 1.
Cell proliferation assay
Effects of tested compounds on the murine macro-
phage-like cell line RAW264.7 (ATCC® TIB-71) viabil-
ity were determined using the colorimetric methyltetra-
zolium (MTT) assay. Briefly, RAW264.7 cells were 
cultured in RPMI 1640 medium supplemented with 10% 
FBS, 2 mM glutamine, 10 mM sodium pyruvate and 2 
mM HEPES. The cells were grown in tissue culture flasks 
(BD Falcon, Germany) in the humidified atmosphere 
under the conditions of 37°C/5% of CO2 gas in the CO2 
incubator (IGO 150 CELLlifeTM, JOUAN, Thermo Fish-
er Scientific, Waltham, MA, USA). The cells were seeded 















Figure 1. Structures of quinoline-arylamidine hybrids.
Effects of quinoline-arylamidine hybrids on  LPS-induced inflammation in RAW 264.7 cells Antonio Periš et al.
Period biol, Vol 121–122, No 3–4, 2020. 163
in 96 micro-well plates at a concentration of 2×104 cells/
cm3 and treated with hybrid compounds 1a–1g at a con-
centration range 100–0.1 μM for 72 h. Additionally, cells 
were pretreated with 10 μM 1a– 1g or Trolox, as a refer-
ence compound, for 2 h and then stimulated with LPS 
(1μg/mL) for 24 h. After 24 and 72 h of incubation, me-
dium was removed and 5 mg/cm3 MTT solution (Merck, 
New Jersey, SAD) was added to each well and incubated 
for 4 h in the CO2 incubator. Then, to each well, DMSO 
was added to dissolve water-insoluble MTT-formazane 
crystals. The Elisa microplate reader (iMark, BIO RAD, 
Hercules, CA, USA) was used for measurement of the 
absorbance at 595 nm. All experiments were performed 
at least three times in triplicates. The percentage of cell 
growth (PG) was calculated using the following equation:
PG= (A compound – A background /A control – A background) × 
100, where Abackground at the adherent cells is the absor-
bance of MTT solution and DMSO; and Acontrol is the 
absorbance of cell suspension grown without tested com-
pounds. 
For the purpose of calculating IC50 values, cells were 
treated for 72 h with compounds at concentrations of 1, 
10, 50 and 100 μM. Briefly, individual concentration ef-
fect curves ware generated by plotting the logarithm of 
the concentration of tested compounds. 
Total antioxidant capacity assay
Total antioxidant capacity of the compounds 1a–1g 
was measured according to the method described previ-
ously on the basis of cell quenching capacity toward the 
2,2’-azino-bis(3-ethybenzthiazoline-6-sulfonic acid 
(ABTS) radical cation (14). ABTS+ was produced by the 
reaction between 7 mM water solution of ABTS (Sigma-
Aldrich, St. Louis, MO, USA) and 2.45 mM ammonium 
persulfate (Sigma-Aldrich, St. Louis, MO, USA) (1:1), 
stored in the dark at room temperature for 12–16 h before 
the use. The ABTS+ solution was then diluted with meth-
anol to obtain an absorbance of 0.700 at 750 nm. Adapt-
ed ABTS+ solution was mixed with 50 μM compounds 
(1:1). Esculetin and Trolox were used as standard com-
pounds and were applied with the same concentration. 
Absorbance (A) was measured after 30 or 60 minutes of 
incubation in the dark at a room temperature after the 
initial mixing. An appropriate solvent blank was run in 
each assay. All the measurements were carried out at least 
three times. Percentage of inhibition of absorbance at 750 
nm was calculated using the formula, ABTS+ scavenging 
effect (%) = 100 – ((As / Ab) × 100) where, Ab was absor-
bance of ABTS radical + methanol, while As was absor-
bance of ABTS radical + tested hybrids/standard. 
Measurement of intracellular ROS by 
flow cytometry 
The intracellular ROS produced by non-stimulated 
(control) and LPS-stimulated macrophages was detected 
by the Fluorometric Intracellular ROS Kit (Sigma-Al-
drich, St. Louis, MO, USA) according to manufacturer’s 
instructions. RAW264.7 cells (5×105 cells/cm3) were 
plated in 24-well plates and left over night in CO2 incuba-
tor. The non-stimulated RAW264.7 cells (5 × 105 per well 
in a 24-well plate) were incubated for 2 h with 10 μM 
hybrid compounds or Trolox. Stimulated cells were pre-
incubated with 10 μM compounds for 2 h and then con-
tinuously stimulated with 1 μg/mL LPS (Lipopolysac-
charides from Escherichia coli O111:B4; Sigma-Aldrich, 
St. Louis, MO, USA) for 24 h. After the treatment cells 
were labeled with 1 μL of 500 x ROS detection reagent 
stock solution in 1 mL of cells suspension for 30 min at 
37 °C in a humidified atmosphere at 5% CO2. The fluo-
rescence intensity was measured by flow cytometry (Fac-
sCanto II, BD Biosciences, USA) and analyzed using 
FlowJo software (Inivai Technologies, USA).
Measurement of nitrite concentration  
Nitrite production as an indicator of nitric oxide (NO) 
intracellular levels was measured in the supernatant of the 
RAW264.7 macrophages (15). Cells (5 × 105 cells/cm3) 
were plated in 24-well plates and left over night in the 
CO2 incubator. Stimulated cells were pre-incubated with 
10 μM compounds for 2 h and then continuously stimu-
lated with 1 μg/mL LPS (Sigma-Aldrich, St. Louis, MO, 
USA) for 24 h. Cell’s supernatant was collected and 
mixed in 1:1 ratio with Griess reagent (1% sulphanil-
amide in 5% phosphoric acid, and 0.1% naphthylethyl-
enediamide, Sigma-Aldrich, St. Louis, MO, USA) dis-
solved in water. The mixture was then incubated at room 
temperature for 15 min in darkness. After 15-min incuba-
tion, the absorbance was read with an ELISA microplate 
reader (iMark, BIO RAD, Hercules, CA, USA). The ni-
trite concentrations were calculated from a sodium nitrite 
standard curve, and the NO concentrations in the super-
natant were determined by comparison with the standard 
curve.
Assessment of lipid peroxidation
Lipid peroxidation was assayed by the measurement of 
the malondialdehyde (MDA) level by the thiobarbituric 
acid reacting substance (TBARS) method (16). 
RAW264.7 cells (5 x 105 cell/mL) were plated in 24-mi-
crowell plates and left over night in the CO2 incubator. 
Then, cells were treated with 10 μM compounds or with 
Trolox for 2 h and then continuously stimulated with 1 
μg/mL LPS (Sigma-Aldrich, St. Louis, MO, USA) for 24 
h. The culture supernatant was collected and mixed in 
ratio 1:2 with 30% trichloroacetic acid (Kemika, Zagreb, 
Croatia) and centrifuged 10 min on 3,500 g.  After cen-
trifugation supernatant was mixed with TBA (2-thiobar-
bituric acid, Sigma-Aldrich, St. Louis, MO, USA) solu-
tion in a ratio 1:1 and then boiled at 95°C for 30 min. 
The absorbance was measured at 532 nm using a UV/VIS 
spectrometer (Lambda 25 UV/VIS, PerkinElmer, USA). 
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1,1,3,3- Tetraethoxypropane (Sigma-Aldrich, St. Louis, 
MO, USA) serial dilution standard curve were performed 
and TBARS values were expressed as μM of malondial-
dehyde (MDA) equivalents.
Statistical analysis 
All described experiments were done in triplicate. A 
nonparametric Mann-Whitney test was applied to analy-
sis antiproliferative effects. Statistical difference between 
all data groups in an experiment were compared using 
one-way analysis of variance (ANOVA) pair wise com-
parison with Dunnett (two sided) analysis. All analyses 
were done with 95% confidence interval (α=0.05).
RESULTS AND DISCUSSION
In this study we examined effects of molecular hybrids 
with 7-chloroquinoline and arylamidine moieties joined 
through flexible -NH-CH2-CH2-O- linker on induction 
of oxidative stress and inflammation in the lipopolysac-
charides (LPS) stimulated RAW 264.7 cells. To deter-
mine optimal concentrations of hybrid compounds for 
further experiments, antiproliferative effects of 1a–1g 
were assessed in the non-stimulated RAW 264.7 cells af-
ter 72 h of treatment. 
As shown in the Figure 2, hybrid compounds 1a–1e in 
0.1 to 10 μM range of concentration were not cytotoxic. 
Only 10 μM compound 1g significantly influenced the 
growth of the RAW 264.7 cells. Statistically significant 
decreases in cell survival were observed when hybrid com-
pounds 1a–1g were applied at highest tested concentration 
of 100 μM. The calculated IC50 values (μM) were for 1a: 
49.6±7.2; for 1b: 39.1±6.6; for 1c: 57.5±2.5; for 1d: 45.4±8.0 
for 1e: 34.3±1.9; for 1f: 75.4±2.3 and for 1g: 1.6±0.8.
Furthermore, the effects of 10 μM hybrid compounds 
1a–1g and Trolox, as a reference compound, on LPS-
stimulated RAW 264.7 cells’ growth were also tested. As 
shown in Figure 3, lipopolysaccharides from E. coli (LPS) 
applied in concentration of 1μg/mL during 24 h had no 
cytotoxic effect on the growth of RAW 264.7 cells. After 
24 h of incubation, Trolox and hybrid compounds 1b, 1d, 
1e, and 1f did not show significant effects on the LPS-
stimulated cells’ growth.  Weak antiproliferative effects 
were shown by the 1a and 1c, while 1g completely inhib-
ited the LPS-stimulated cells (Figure 3).  Based on de-
scribed results, we excluded the molecular hybrid 1g and 
selected the 10 μM concentration of hybrid compounds 
1a–1f as the optimal concentration for the subsequent 
experiments.
It is well known that normal cellular metabolic pro-
cess involving mitochondrial respiratory chain produces 
ROS while excessive ROS production results in mito-
chondrial dysfunction which is strongly associated with 
other pathological conditions, including inflammation 
(17). Macrophages in vivo and in vitro upon stimulation 
by LPS exhibit inflammatory responses by excessive ac-
cumulation of nitric oxide and superoxide anion whose 
interaction result in different pathophysiological condi-
tions (11). By analyzing antioxidant capacity of the new 
synthesized hybrids 1a–1f we wanted to determine if 
there is a correlation between radical scavenging capac-
ity of tested compounds, redox status in the LPS-stim-
ulated RAW 264.7 cells and their responsiveness to 
tested compounds. 
In our experimental conditions, 1a–1f did not induce 
changes in ROS levels in the non-stimulated RAW 
264.7 cells (data not shown). As shown in the Figure 4, 
intracellular levels of ROS in the RAW cells stimulated 
by LPS for 24 h increased almost two times compared 
Figure 2. Inhibitory effects of molecular quinoline-arylamidine hybrids 1a–1g on the growth of the RAW 264.7 cells. Cytotoxicity 
was analyzed after 72 h of incubation using the MTT survival assay. The percentage of treated cells growth inhibition was calculated relative 
to the growth of untreated (control) cells. Data are presented as the mean value ± SD of three independent experiments done in triplicates. 
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to non-stimulated (control) cells. In LPS-activated RAW 
264.7 cells we recorded a slight decrease in the ROS 
accumulation after treatment with all tested compounds 
(Figure 4).
Since free-radical scavenging is one of the well-known 
mechanisms by which many compounds act as antioxi-
dants we evaluated in vitro antioxidant capacity of tested 
compounds by 2,2’-azino-bis(3-ethybenzthiazoline-
Figure 3. Cytotoxic effects of 10 μM quinoline-arylamidine hybrids 1a–1g and Trolox on the RAW 264.7 cells’ growth after pre-
treatment for 2 h and stimulation with 1μg/mL LPS for 24 h. LPS: control cells stimulated by lipopolysaccharides (LPS) for 24 h. Cyto-
toxicity was analysed using the MTT survival assay. The percentage of treated cells growth inhibition was calculated relative to the growth of 
untreated (control) cells. Data are presented as the mean value ± SD of three independent experiments done in triplicates
Figure 4. Effect of hybrid compounds 1a–1f on the RAW264.7 intracellular ROS accumulation. Cells (5×105 per well in a 96-well 
plate) were pre-incubated with 10 µM hybrids for 2 h and then continuously stimulated with 1 µg/mL LPS for 24 h. Control: non-treated and 
non-stimulated cells. LPS: cells stimulated by LPS for 24 h. Data are given as mean fluorescence of ROS level with ± SD. One-way ANOVA 
with Dunnett analysis (α<0.05) were used to examined differences between control cells and by hybrids treated cells.
Table 1. Radical scavenging capacity (RSC) of tested hybrid compounds 1a–1f*
Compound 1a 1b 1c 1d 1e 1f Trolox Esculetin
RSC (%) 14.0±2.2 0.2±0.1 3.7±0.3 0.2±0.1 0.6±0.1 1.4±0.2 91.5±2.0 91.4±1.5
*2,2-Azinobis-3-ethylbenzothiazoline-6-sulfonic acid cation (ABTS+) scavenging effect expressed as mean (n=3) values ±SD after 60 minutes of 
incubation. 
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6-sulfonic acid (ABTS) radical cation method. Obtained 
results showed that in vitro scavenger activity of tested 
hybrids 1a–1f is negligible (0.2 to 14.2 respectively) com-
pared to reference compounds, Trolox and Esculetin 
(Table 1). 
As nitric oxide (NO) is an important pro-inflammato-
ry mediator produced by inducible nitric oxide synthase 
in macrophages (5, 12), we examined whether or not 
tested hybrid compounds 1a–1f could reduce the LPS-
induced generation of NO in the RAW 264.7 cells. Ob-
tained results showed that LPS stimulation led to statisti-
cally significant increase in NO production (to 169.2±9.4 
μM) in LPS stimulated cells compared to the non-treated 
and non-stimulated control cells (26.7±2.4 μM). We 
found that 10 μM hybrid compounds 1a, 1b, and 1e sig-
nificantly reduced production of NO in LPS-activated 
macrophages by about 20–25% compared to LPS in-
duced control cells, indicating their potential as a NO-
scavenging compounds. In the applied concentration 
Trolox had no effect on the NO production in LPS stim-
ulated cells compared to LPS control cells (Figure 5a). 
Nitrosative and/or oxidative stress-induced lipid per-
oxidation is detrimental because it alters the biological 
properties of the cellular membrane, such as degree of 
fluidity and inactivated membrane-bound receptors and 
enzymes, which impairs normal cellular function and 
increases tissue permeability (18). Therefore, lipid per-
oxidation products such as malonylaldehyde (MDA) are 
often used as markers of oxidative/nitrosative damage 
(19). Thiobarbitoric acid (TBA) assay is the most com-
monly used method for determination of the MDA in 
biological fluids. As shown in Figure 5b, LPS stimulation 
of the RAW 264.7 cells increased TBARS production for 
more than double in the LPS stimulated cells compared 
to the non-stimulated control cells. The 2 h pretreatment 
with 10 μM hybrid compounds 1a–1d caused statisti-
cally significant decrease in the MDA accumulation in 
the LPS-stimulated RAW 264.7 cells compared to control 
cells and completely restored the TBARS content to con-
Figure 5. Effect of hybrid compounds on NO production (a) and TBARS generation (b) in LPS stimulated RAW264.7 cells. Cells 
(5 × 105 per well in a 96-well plate) were pre-incubated with 10 µM hybrids for 2 h and then continuously stimulated with 1 µg/mL LPS for 
24 h. Control: non-treated and non-stimulated cells. LPS: cells stimulated by LPS for 24 h. Results are expressed as mean values with ±SD. 
One-way ANOVA with Dunnett analysis (α<0.05) were used to examine differences between LPS stimulated cells and compound-treated cells.
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trol levels. Obtained results are in line with findings that 
bifunctional hybrids containing 7-chloroquinoline have 
a very good potential to demonstrate significant anti-in-
flammatory activity (4, 20, 21).
CONCLUSIONS
The results presented in this study demonstrate that 
molecular hybrids with 7-chloroquinoline and arylami-
dine moieties joined through flexible 2-aminoethanol 
linker slightly modulated the production of NO and ROS 
and did not present significant ABTS radical-scavenger 
activity. At the same time, our results suggest a pharma-
cological potential of this class of compounds since a 
markedly decreased accumulation of lipid peroxidation 
products in the LPS-stimulated RAW 264.7 cells was 
noticed. Further studies are necessary to investigate 
mechanisms of action of these compounds. Compounds 
from this series will serve as a template for the future 
design of new analogues with improved antitumor and 
anti-inflammatory activities. 
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